As of 2025-10-15, the EV/EBITDA ratio of Cue Biopharma Inc (CUE) is -0.93. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CUE's latest enterprise value is 36.39 mil USD. CUE's TTM EBITDA according to its financial statements is -39.08 mil USD. Dividing these 2 quantities gives us the above CUE EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.5x - 14.5x | 13.3x |
| Forward P/E multiples | 16.9x - 35.4x | 20.2x |
| Fair Price | (8.28) - (7.07) | (8.19) |
| Upside | -1138.3% - -986.5% | -1127.5% |
| Date | EV/EBITDA |
| 2025-10-09 | -1.18 |
| 2025-10-08 | -1.05 |
| 2025-10-07 | -0.84 |
| 2025-10-06 | -0.79 |
| 2025-10-03 | -0.80 |
| 2025-10-02 | -0.78 |
| 2025-10-01 | -0.79 |
| 2025-09-30 | -0.78 |
| 2025-09-29 | -0.78 |
| 2025-09-26 | -0.76 |
| 2025-09-25 | -0.72 |
| 2025-09-24 | -0.76 |
| 2025-09-23 | -0.76 |
| 2025-09-22 | -0.75 |
| 2025-09-19 | -0.68 |
| 2025-09-18 | -0.80 |
| 2025-09-17 | -0.78 |
| 2025-09-16 | -0.82 |
| 2025-09-15 | -0.82 |
| 2025-09-12 | -0.82 |
| 2025-09-11 | -0.87 |
| 2025-09-10 | -0.86 |
| 2025-09-09 | -0.88 |
| 2025-09-08 | -0.89 |
| 2025-09-05 | -0.90 |
| 2025-09-04 | -0.91 |
| 2025-09-03 | -0.92 |
| 2025-09-02 | -0.92 |
| 2025-08-29 | -0.90 |
| 2025-08-28 | -0.94 |
| 2025-08-27 | -0.99 |
| 2025-08-26 | -1.02 |
| 2025-08-25 | -0.97 |
| 2025-08-22 | -0.99 |
| 2025-08-21 | -0.96 |
| 2025-08-20 | -0.95 |
| 2025-08-19 | -0.97 |
| 2025-08-18 | -0.97 |
| 2025-08-15 | -0.99 |
| 2025-08-14 | -0.92 |
| 2025-08-13 | -0.96 |
| 2025-08-12 | -0.92 |
| 2025-08-11 | -1.00 |
| 2025-08-08 | -1.00 |
| 2025-08-07 | -0.96 |
| 2025-08-06 | -0.90 |
| 2025-08-05 | -1.01 |
| 2025-08-04 | -0.86 |
| 2025-08-01 | -0.81 |
| 2025-07-31 | -0.84 |